FDA clears Promega OncoMate MSI Dx system in Industry News Create PDFJuly 29, 2021—Promega’s OncoMate MSI Dx analysis system has been cleared by the FDA as an IVD medical device to determine microsatellite instability status in colorectal cancer tumors. Pages: 1 2 Promega 2021-07-29 CAP TODAY Previous Post Next Post